Ingalls & Snyder LLC Bristol Myers Squibb CO Transaction History
Ingalls & Snyder LLC
- $2.55 Billion
- Q4 2024
A detailed history of Ingalls & Snyder LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ingalls & Snyder LLC holds 12,700 shares of BMY stock, worth $691,261. This represents 0.03% of its overall portfolio holdings.
Number of Shares
12,700
Previous 12,700
-0.0%
Holding current value
$691,261
Previous $657,000
9.28%
% of portfolio
0.03%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,745Shares Held
1.57BCall Options Held
27.9MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.23 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.18 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.28 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...